Taiwan FDA registration c45ff11208cdb8a3c2f84700831a3626

The second generation of the Roche EGFR Gene Mutation Test Kit

TW: 羅氏EGFR基因突變檢驗套組第二代
Taiwan flagTaiwan·Risk Class 3·Roche Molecular Systems, Inc.;; ROCHE DIAGNOSTICS GMBH·Registered Oct 27, 2016 – Oct 27, 2026Active
Registration details
Analysis ID
c45ff11208cdb8a3c2f84700831a3626
Customs Code
DHA05602893508
Company information
Manufacturer Country
United States;;Germany
Authorized Representative
ROCHE DIAGNOSTICS LTD.
Product details
Intended Use
This product is an instant PCR detection reagent, targeting the DNA of human non-small cell lung cancer (NSCLC) tumor tissue with formalin-fixed paraffin-embedded (FFPET) or the epidermal growth factor receptor (EGFR) gene exon 18, 19, and plasma of human non-small cell lung cancer (NSCLC) patients. Mutations of 20 and 21 are qualitatively detected and identified. This test can assist in the selection of human non-small cell lung cancer (NSCLC) patients who can be treated with EGFR tyrosine kinase inhibitor (TKI). This product is used in plasma to further semi-quantitatively measure EGFR gene 18, 19, 20 and 21 mutations in human plasma collected over a period of time, and to assist in the management of human non-small cell lung cancer (NSCLC) patients. Formalin-fixed paraffin-embedded (FFPET) samples were treated using the Roche DNA Extraction Kit, while plasma samples were treated with the Roche Free DNA Extraction Kit. This product is used with the Cobas Z 480 analyzer for automated amplification reaction and detection procedures.
Product Type (Level 1)
B Hematology, pathology, and genetics
Product Type (Level 2)
B.4020 Analysis of specific tests
Import Information
import
Dates and status
Registration Date
Oct 27, 2016
Expiry Date
Oct 27, 2026
About this record

Access comprehensive regulatory information for The second generation of the Roche EGFR Gene Mutation Test Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number c45ff11208cdb8a3c2f84700831a3626 and manufactured by Roche Molecular Systems, Inc.;; ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices